NASDAQ · Biotechnology

SPRC (SPRC) Stock

$7.12 -18.16% NASDAQ: SPRC Healthcare

Valuation

MetricValue
Price$7.12
Market Cap$411814
P/E Ratio—
P/B Ratio0.07
P/S Ratio0.31
EPS (TTM)$0.00
52-Week High$80.10
52-Week Low$2.98
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-300.00%
ROA-150.00%
ROCE-150.00%
Gross Margin-900.00%
Operating Margin-900.00%
Net Margin-14.23%
Debt/Equity0.09
Current Ratio2.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$3.0M$1.0M$1.0M
Operating Profit$-6.0M$-7.0M$-6.0M$-7.0M$-9.0M
Net Profit$-6.0M$-3.0M$-5.0M$-6.0M$-12.0M
EPS$-3311.10$-666.90$-649.35$-9.72$0.00
Op Margin-539.6%-547.9%-200.5%-560.2%-1022.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.0M$11.0M$11.0M$10.0M$8.0M
Total Liabilities$2.0M$4.0M$2.0M$1.0M$2.0M
Cash$7.0M$4.0M$2.0M$2.0M$5.0M
Borrowings$1.0M$0$0$0$0

Latest News

NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome NewMediaWire · Jul 15, 2026 SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome GlobeNewswire · Jul 15, 2026 SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum GlobeNewswire · Jun 4, 2026 NeuroThera Labs Inc. Announces Closing of Acquisition of Majority Stake in CliniQuantum Ltd. NewMediaWire · Jun 3, 2026 SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum GlobeNewswire · May 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-8.0M$-6.0M$-5.0M$-4.0M
Investing Cash Flow$0$-12.0M$-1.0M$-2.0M$-1.0M
Financing Cash Flow$0$3.0M$0$0$0
Net Cash Flow$5.0M$-3.0M$-1.0M$-1.0M$3.0M
Free Cash Flow$-5.0M$-13.0M$-6.0M$-5.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-696.44%
Quick Ratio2.38
Interest Coverage—
Return 1Y-92.43%
Return 3Y-99.82%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.55%
Institutions Float Held0.55%
Institutional HolderSharesReport Date
UBS Group AG3,1462026-03-31
SBI Securities Co., Ltd.12026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARTL $0.77 +1.96% -0.12 $1.80M 0.00%
AZTR $0.14 +0.80% -0.09 $1.49M 0.00%
INDP $1.39 -3.82% -0.06 $2.43M 0.00%
JSPR $0.63 +1.48% -0.21 $10.24M 0.00%
LIPOLipella Pharmaceuticals Inc. $0.07 +0.00% -0.05 $300354 0.00%

About SPRC

SPRC is led by CEO Oz Adler, employs 2 people, headquartered in IL, publicly traded since 2021.

SPRC stock trades at $7.12 with a market capitalization of $411814. The stock is valued at price-to-book of 0.07, price-to-sales of 0.31. Over the past 52 weeks the stock has ranged between $2.98 and $80.10, and currently trades 91.1% below its 52-week high.

On profitability, SPRC generates a return on equity (ROE) of -300.00%, return on capital employed of -150.00%, an operating margin of -900.00%, a net profit margin of -14.23%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides